CHATSWORTH, Calif., May 26, 2009 (GLOBE NEWSWIRE) -- IRIS International, Inc. (Nasdaq:IRIS), a leading manufacturer of urinalysis systems and consumables for use in hospitals and commercial laboratories worldwide, “following resumption of full-scale shipments of its new iChem(r)Velocity(tm) Automated Urine Chemistry Analyzers to the international market, remains on track for achieving its previously announced guidance for the current second quarter ending June 30, and for the full year ending December 31, 2009,” Cesar Garcia, Chairman and Chief Executive Officer, told shareholders attending its Annual Meeting held here on Friday.
